ANIP logo

ANI Pharmaceuticals (ANIP) Total Assets

Annual Total Assets

$904.42 M
+$144.34 M+18.99%

31 December 2023

ANIP Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Assets

$1.29 B
+$366.62 M+39.82%

30 September 2024

ANIP Quarterly Total Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANIP Total Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+19.0%+44.7%
3 y3 years+96.1%+173.7%
5 y5 years+110.0%+181.8%

ANIP Total Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+96.1%at high+173.7%
5 y5 yearsat high+110.0%at high+181.8%
alltimeall timeat high>+9999.0%at high>+9999.0%

ANI Pharmaceuticals Total Assets History

DateAnnualQuarterly
Sept 2024
-
$1.29 B(+39.8%)
June 2024
-
$920.75 M(+0.7%)
Mar 2024
-
$914.52 M(+1.1%)
Dec 2023
$904.42 M(+19.0%)
$904.42 M(+1.6%)
Sept 2023
-
$889.91 M(+3.6%)
June 2023
-
$859.34 M(+12.3%)
Mar 2023
-
$765.22 M(+0.7%)
Dec 2022
$760.09 M(-1.5%)
$760.09 M(+2.8%)
Sept 2022
-
$739.11 M(-1.6%)
June 2022
-
$751.33 M(+0.9%)
Mar 2022
-
$744.85 M(-3.5%)
Dec 2021
$771.60 M(+67.3%)
$771.60 M(+64.0%)
Sept 2021
-
$470.45 M(-2.0%)
June 2021
-
$480.16 M(+3.5%)
Mar 2021
-
$463.84 M(+0.6%)
Dec 2020
$461.19 M(+1.0%)
$461.19 M(-0.3%)
Sept 2020
-
$462.58 M(-0.6%)
June 2020
-
$465.39 M(-3.5%)
Mar 2020
-
$482.23 M(+5.6%)
Dec 2019
$456.79 M(+6.1%)
$456.79 M(+0.0%)
Sept 2019
-
$456.77 M(+2.2%)
June 2019
-
$446.91 M(+2.9%)
Mar 2019
-
$434.39 M(+0.9%)
Dec 2018
$430.60 M(+4.5%)
$430.60 M(-2.0%)
Sept 2018
-
$439.44 M(+3.6%)
June 2018
-
$424.18 M(+1.5%)
Mar 2018
-
$418.02 M(+1.4%)
Dec 2017
$412.14 M(+27.7%)
$412.14 M(+11.2%)
Sept 2017
-
$370.47 M(+3.1%)
June 2017
-
$359.22 M(+0.6%)
Mar 2017
-
$357.14 M(+10.6%)
Dec 2016
$322.86 M(+13.2%)
$322.86 M(+1.1%)
Sept 2016
-
$319.38 M(+3.7%)
June 2016
-
$308.00 M(+5.6%)
Mar 2016
-
$291.59 M(+2.2%)
Dec 2015
$285.26 M(+9.9%)
$285.26 M(+0.7%)
Sept 2015
-
$283.28 M(+4.9%)
June 2015
-
$270.12 M(+1.6%)
Mar 2015
-
$265.99 M(+2.5%)
Dec 2014
$259.56 M(+483.3%)
$259.56 M(+141.1%)
Sept 2014
-
$107.64 M(+12.8%)
June 2014
-
$95.42 M(-1.3%)
Mar 2014
-
$96.65 M(+117.2%)
Dec 2013
$44.50 M(+14.8%)
$44.50 M(+2.8%)
Sept 2013
-
$43.29 M(+3.9%)
June 2013
-
$41.66 M(+17.8%)
Mar 2013
-
$35.36 M(-8.8%)
Dec 2012
$38.77 M
$38.77 M(-10.3%)
Sept 2012
-
$43.21 M(-8.6%)
June 2012
-
$47.29 M(-13.3%)
DateAnnualQuarterly
Mar 2012
-
$54.57 M(-12.5%)
Dec 2011
$62.38 M(+39.3%)
$62.38 M(-16.7%)
Sept 2011
-
$74.89 M(+75.1%)
June 2011
-
$42.76 M(-24.7%)
Mar 2011
-
$56.81 M(+26.9%)
Dec 2010
$44.77 M(+22.9%)
$44.77 M(+9.8%)
Sept 2010
-
$40.76 M(-21.3%)
June 2010
-
$51.78 M(+9.4%)
Mar 2010
-
$47.32 M(+29.9%)
Dec 2009
$36.44 M(+106.1%)
$36.44 M(+128.3%)
Sept 2009
-
$15.96 M(+67.5%)
June 2009
-
$9.53 M(-27.9%)
Mar 2009
-
$13.22 M(-25.2%)
Dec 2008
$17.68 M(-43.4%)
$17.68 M(-10.8%)
Sept 2008
-
$19.82 M(-18.5%)
June 2008
-
$24.33 M(-15.3%)
Mar 2008
-
$28.72 M(-8.1%)
Dec 2007
$31.24 M(+39.7%)
$31.24 M(-6.5%)
Sept 2007
-
$33.42 M(-4.9%)
June 2007
-
$35.16 M(+84.6%)
Mar 2007
-
$19.05 M(-14.9%)
Dec 2006
$22.37 M(+133.6%)
$22.37 M(+108.4%)
Sept 2006
-
$10.74 M(+118.9%)
June 2006
-
$4.90 M(-34.5%)
Mar 2006
-
$7.48 M(-21.8%)
Dec 2005
$9.57 M(-46.3%)
$9.57 M(-11.2%)
Sept 2005
-
$10.78 M(-13.7%)
June 2005
-
$12.49 M(-17.8%)
Mar 2005
-
$15.21 M(-14.7%)
Dec 2004
$17.83 M(+86.4%)
$17.83 M(-15.4%)
Sept 2004
-
$21.07 M(-9.8%)
June 2004
-
$23.35 M(+169.3%)
Mar 2004
-
$8.67 M(-9.4%)
Dec 2003
$9.57 M(+62.7%)
$9.57 M(-12.2%)
Sept 2003
-
$10.90 M(+297.8%)
June 2003
-
$2.74 M(-30.4%)
Mar 2003
-
$3.93 M(-33.1%)
Dec 2002
$5.88 M(+18.1%)
$5.88 M(+1.7%)
Sept 2002
-
$5.78 M(+169.9%)
June 2002
-
$2.14 M(-40.9%)
Mar 2002
-
$3.63 M(-27.2%)
Dec 2001
$4.98 M(+62.4%)
$4.98 M(-23.3%)
Sept 2001
-
$6.49 M(+24.6%)
June 2001
-
$5.21 M(-7.6%)
Mar 2001
-
$5.64 M(+83.8%)
Dec 2000
$3.07 M(-46.9%)
$3.07 M(-17.7%)
Sept 2000
-
$3.73 M(-2.8%)
June 2000
-
$3.83 M(-27.6%)
Mar 2000
-
$5.29 M
Dec 1999
$5.78 M(+67.6%)
-
Dec 1998
$3.45 M
-

FAQ

  • What is ANI Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals annual total assets year-on-year change?
  • What is ANI Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for ANI Pharmaceuticals?
  • What is ANI Pharmaceuticals quarterly total assets year-on-year change?

What is ANI Pharmaceuticals annual total assets?

The current annual total assets of ANIP is $904.42 M

What is the all time high annual total assets for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high annual total assets is $904.42 M

What is ANI Pharmaceuticals annual total assets year-on-year change?

Over the past year, ANIP annual total assets has changed by +$144.34 M (+18.99%)

What is ANI Pharmaceuticals quarterly total assets?

The current quarterly total assets of ANIP is $1.29 B

What is the all time high quarterly total assets for ANI Pharmaceuticals?

ANI Pharmaceuticals all-time high quarterly total assets is $1.29 B

What is ANI Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, ANIP quarterly total assets has changed by +$397.46 M (+44.66%)